PLASMA VONWILLEBRAND-FACTOR AND THROMBOMODULIN AS MARKERS OF VASCULAR DISORDERS IN PATIENTS UNDERGOING REGULAR HEMODIALYSIS THERAPY

被引:0
|
作者
OHNO, Y
TOMURA, S
DEGUCHI, F
NAKAMURA, Y
CHIDA, Y
MARUMO, F
机构
[1] SEKISUI CHEM CO LTD,DIV MED,OSAKA,JAPAN
[2] NAKANO GEN HOSP,DEPT INTERNAL MED,TOKYO,JAPAN
[3] TOKYO MED & DENT UNIV,DEPT INTERNAL MED,TOKYO 113,JAPAN
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:946 / 946
页数:1
相关论文
共 50 条
  • [21] INVESTIGATIONS ON MULTIMERIC STRUCTURE OF PLATELET VONWILLEBRAND-FACTOR IN PATIENTS WITH HEREDITARY DISORDERS OF PLATELET-FUNCTION
    VIGH, Z
    SCHARRER, I
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 355 - 355
  • [22] PROTEOLYSIS OF VONWILLEBRAND-FACTOR AFTER THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    FEDERICI, AB
    BERKOWITZ, SD
    ZIMMERMAN, TS
    MANNUCCI, PM
    BLOOD, 1992, 79 (01) : 38 - 44
  • [23] Psychiatric disorders among patients undergoing hemodialysis therapy
    Fukunishi, I
    Kitaoka, T
    Shirai, T
    Kino, K
    Kanematsu, E
    Sato, Y
    NEPHRON, 2002, 91 (02) : 344 - 347
  • [24] SUBUNIT COMPOSITION OF PLASMA VONWILLEBRAND-FACTOR (VWF) IN 2 UREMIC PATIENTS WITH ACQUIRED VWF ABNORMALITIES
    CASTAMAN, G
    RODEGHIERO, F
    LATTUADA, A
    MANNUCCI, PM
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (01) : 183 - 183
  • [25] BLEEDING-TIME IN TREATED PATIENTS WITH SEVERE VONWILLEBRAND DISEASE IS NOT CORRECTED ONLY BY GIVING NORMAL MULTIMERIC PLASMA VONWILLEBRAND-FACTOR
    MANNUCCI, PM
    MOIA, M
    ALTIERI, D
    MONTEAGUDO, J
    CASTILLO, R
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 362 - 362
  • [26] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND VONWILLEBRAND-FACTOR PLASMA-LEVELS AS MARKERS OF ENDOTHELIAL INVOLVEMENT IN PATIENTS WITH RAYNAUDS-PHENOMENON
    MARASINI, B
    CUGNO, M
    BASSANI, C
    STANZANI, M
    BOTTASSO, B
    AGOSTONI, A
    INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL, 1992, 11 (04): : 375 - 382
  • [27] UREMIC PATIENTS HAVE NORMAL PLASMA AND PLATELET VONWILLEBRAND-FACTOR STRUCTURE, REGARDLESS OF BLEEDING-TIME
    CASTAMAN, G
    RODEGHIERO, F
    LATTUADA, A
    CONZ, P
    LAGRECA, G
    MANNUCCI, PM
    THROMBOSIS RESEARCH, 1993, 70 : S101 - S101
  • [28] CORRECTION OF THE BLEEDING-TIME IN TREATED PATIENTS WITH SEVERE VONWILLEBRAND DISEASE IS NOT SOLELY DEPENDENT ON THE NORMAL MULTIMERIC STRUCTURE OF PLASMA VONWILLEBRAND-FACTOR
    MANNUCCI, PM
    MOIA, M
    REBULLA, P
    ALTIERI, D
    MONTEAGUDO, J
    CASTILLO, R
    AMERICAN JOURNAL OF HEMATOLOGY, 1987, 25 (01) : 55 - 65
  • [29] PLASMA COAGULATION AND FIBRINOLYSIS PARAMETERS IN PATIENTS WITH COLLAGEN DISEASES, AND ANALYSIS OF THE MULTIMERIC STRUCTURE OF VONWILLEBRAND-FACTOR (VWF)
    KAGAWA, H
    OKUBO, S
    YASUNAGA, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1991, 54 (05) : 429 - 439
  • [30] ANESTHESIA AFFECTS PLASMA-CONCENTRATIONS OF VASOPRESSIN, VONWILLEBRAND-FACTOR AND COAGULATION FACTOR-VIII IN CARDIAC SURGICAL PATIENTS
    KUITUNEN, A
    HYNYNEN, M
    SALMENPERA, M
    RASI, V
    JARVINEN, A
    SCHEININ, M
    NEUVONEN, PJ
    FYHRQUIST, F
    BRITISH JOURNAL OF ANAESTHESIA, 1993, 70 (02) : 173 - 180